IP Library › Granted Patent US 12,545,953
Granted Patent B2
US 12,545,953 · App. 17/972,442 · Granted Feb 10, 2026

Immobilization-based systems and methods for genetic analysis and other applications

Inventors: David A. Weitz (Cambridge, MA); Huidan Zhang (Cambridge, MA); John Heyman (Cambridge, MA)
Assignee: President and Fellows of Harvard College
C12Q1/6855B01F23/40B01J13/02C12Q1/68C12Q1/6816C12Q1/6827
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,545,953
App. No.
17/972,442
Granted
Feb 10, 2026
Kind
B2
Abstract

The present invention generally relates to microfluidics and labeled nucleic acids. Certain aspects are generally directed to containing cells in gels, such as agarose gels, and determining nucleic acids within the cells, e.g., while contained within the gels. The nucleic acids may be, for example, genomic DNA, mRNA, transcriptomes, or the like. In some embodiments, for instance, both genomic DNA and RNA (e.g., as in a transcriptome) from a cell may be determined. In some cases, the nucleic acids may be attached to beads for sequencing or other purposes. Such systems may be useful, for example, for high-throughput sequencing or other applications.

Claims (26)

1 . A method of simultaneous preparing mRNA and gDNA from a cell, comprising:

lysing cells within gel droplets to release gDNA and mRNA from the cells;

fragmenting the gDNA after release from the cells;

attaching the gDNA to a first set of oligonucleotides comprising a first set of barcode sequences within the gel droplets;

forming cDNA from the mRNA; and

attaching the cDNA to a second set of oligonucleotides comprising a second set of barcode sequences within the gel droplets,

wherein the first and second sets of oligonucleotides are different.

2 . The method of claim 1 , wherein at least some of the gel droplets comprise agarose.

3 . The method of claim 1 , wherein the cells are contained within the gel droplets at no more than about 1 cell/droplet.

4 . The method of claim 1 , wherein the gel droplets have an average diameter of no more than about 1 mm.

5 . The method of claim 1 , wherein at least some of the gel droplets are contained within a microfluidic channel.

6 . The method of claim 1 , wherein fragmenting the gDNA comprises exposing the gDNA to a restriction endonuclease.

7 . The method of claim 1 , further comprising forming cDNA from the mRNA using a reverse transcriptase.

8 . The method of claim 1 , wherein attaching the gDNA to the first set of oligonucleotides comprises ligating at least some of the gDNA to the first set of oligonucleotides.

9 . The method of claim 1 , wherein attaching the cDNA to the second set of oligonucleotides comprises ligating at least some of the cDNA to the second set of oligonucleotides.

10 . The method of claim 1 , wherein the first set of barcode sequences and the second set of barcode sequences have at least one barcode sequence of at least 5 nt in common.

11 . The method of claim 1 , wherein the first set of oligonucleotides is attached to particles within the gel droplets.

12 . The method of claim 11 , wherein the second set of oligonucleotides is attached to the particles within the gel droplets.

13 . The method of claim 11 , wherein at least some of the particles comprise hydrogel particles.

14 . The method of claim 11 , wherein the particles have an average diameter of no more than about 1 mm.

15 . The method of claim 11 , wherein at least some oligonucleotides of the first set of oligonucleotides are covalently bonded to the particles.

16 . The method of claim 11 , further comprising amplifying at least some oligonucleotides of the first set of oligonucleotides and/or the second set of oligonucleotides.

17 . The method of claim 16 , further comprising encapsulating at least some of the gel droplets within a fluidic droplet prior to amplifying the oligonucleotides.

18 . The method of claim 16 , further comprising releasing at least some oligonucleotides of the first set of oligonucleotides from the particles.

19 . The method of claim 16 , further comprising bursting the fluidic droplet after amplifying the oligonucleotides.

20 . The method of claim 16 , further comprising sequencing at least some oligonucleotides of the first set of oligonucleotides and/or the second set of oligonucleotides.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2023
From: WEITZ, DAVID A.; ZHANG, HUIDAN; HEYMAN, JOHN
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 062448/0104 →
Continuity (3)
Continuation 16094766
Provisional Application 62324407 · Apr 19, 2016
Related Publication 20250215485A1 · Jul 3, 2025
References Cited (175)
US 7041481B2 · Anderson et al. · 2006 [cited by applicant]
US 7323305B2 · Leamon et al. · 2008 [cited by applicant]
US 7708949B2 · Stone et al. · 2010 [cited by applicant]
US RE41780E · Anderson et al. · 2010 [cited by applicant]
US 7842457B2 · Berka et al. · 2010 [cited by applicant]
US 8337778B2 · Stone et al. · 2012 [cited by applicant]
US 8765485B2 · Link et al. · 2014 [cited by applicant]
US 9017948B2 · Weitz et al. · 2015 [cited by applicant]
US 9029085B2 · Agresti et al. · 2015 [cited by applicant]
US 9068210B2 · Weitz et al. · 2015 [cited by applicant]
US 9664619B2 · Boehm et al. · 2017 [cited by applicant]
US 9816121B2 · Weitz et al. · 2017 [cited by applicant]
US 9850526B2 · Weitz et al. · 2017 [cited by applicant]
US 10151429B2 · Weitz et al. · 2018 [cited by applicant]
US 10221437B2 · Weitz et al. · 2019 [cited by applicant]
US 10508294B2 · Weitz et al. · 2019 [cited by applicant]
US 10683524B2 · Weitz et al. · 2020 [cited by applicant]
US 10738337B2 · Weitz et al. · 2020 [cited by applicant]
US 10876156B2 · Weitz et al. · 2020 [cited by applicant]
US 10941430B2 · Weitz et al. · 2021 [cited by applicant]
US 11052368B2 · Weitz et al. · 2021 [cited by applicant]
US 11746367B2 · Weitz et al. · 2023 [cited by applicant]
US 20040180346A1 · Anderson et al. · 2004 [cited by applicant]
US 20050130173A1 · Leamon et al. · 2005 [cited by applicant]
US 20050172476A1 · Stone et al. · 2005 [cited by applicant]
US 20060040297A1 · Leamon et al. · 2006 [cited by applicant]
US 20070003442A1 · Link et al. · 2007 [cited by applicant]
US 20070195127A1 · Anh et al. · 2007 [cited by applicant]
US 20080176233A1 · Nilsen et al. · 2008 [cited by applicant]
US 20080241841A1 · Murakawa et al. · 2008 [cited by applicant]
US 20090197248A1 · Griffiths et al. · 2009 [cited by applicant]
US 20100069250A1 · White, III et al. · 2010 [cited by applicant]
US 20100105112A1 · Holtz et al. · 2010 [cited by applicant]
US 20100124759A1 · Wang et al. · 2010 [cited by applicant]
US 20100136544A1 · Agresti et al. · 2010 [cited by applicant]
US 20100172803A1 · Stone et al. · 2010 [cited by applicant]
US 20110087016A1 · Suo · 2011 [cited by applicant]
US 20110257046A1 · Schroeder · 2011 [cited by applicant]
US 20120132288A1 · Weitz et al. · 2012 [cited by applicant]
US 20120164633A1 · Laffler · 2012 [cited by applicant]
US 20120164652A1 · Clemens et al. · 2012 [cited by applicant]
US 20130189700A1 · So et al. · 2013 [cited by applicant]
US 20130225418A1 · Watson · 2013 [cited by applicant]
US 20130274117A1 · Church et al. · 2013 [cited by applicant]
US 20130323732A1 · Anderson et al. · 2013 [cited by applicant]
US 20140057799A1 · Church et al. · 2014 [cited by applicant]
US 20140199730A1 · Weitz et al. · 2014 [cited by applicant]
US 20140199731A1 · Weitz et al. · 2014 [cited by applicant]
US 20140227684A1 · Hindson et al. · 2014 [cited by applicant]
US 20150057163A1 · Rotem et al. · 2015 [cited by applicant]
US 20150209785A1 · Esmail et al. · 2015 [cited by applicant]
US 20150298091A1 · Weitz · 2015 [cited by examiner]
US 20150353999A1 · Weitz et al. · 2015 [cited by applicant]
US 20150376609A1 · Hindson · 2015 [cited by examiner]
US 20160265043A1 · Geng et al. · 2016 [cited by applicant]
US 20170009274A1 · Abate et al. · 2017 [cited by applicant]
US 20170029813A1 · Weitz et al. · 2017 [cited by applicant]
US 20170183701A1 · Weitz et al. · 2017 [cited by applicant]
US 20170191127A1 · Hodges et al. · 2017 [cited by applicant]
US 20180016622A1 · Weitz et al. · 2018 [cited by applicant]
US 20180023109A1 · Weitz et al. · 2018 [cited by applicant]
US 20180056293A1 · Weitz et al. · 2018 [cited by applicant]
US 20180066305A1 · Weitz et al. · 2018 [cited by applicant]
US 20180087078A1 · Weitz et al. · 2018 [cited by applicant]
US 20180119212A1 · Weitz et al. · 2018 [cited by applicant]
US 20180171373A1 · Weitz et al. · 2018 [cited by applicant]
US 20190127782A1 · Regev et al. · 2019 [cited by applicant]
US 20190127789A1 · Weitz et al. · 2019 [cited by applicant]
US 20190330683A1 · Link et al. · 2019 [cited by applicant]
US 20190351417A1 · Bharadwaj et al. · 2019 [cited by applicant]
US 20200002741A1 · Weitz et al. · 2020 [cited by applicant]
US 20200157593A1 · Weitz et al. · 2020 [cited by applicant]
US 20210254129A1 · Weitz et al. · 2021 [cited by applicant]
US 20210340597A1 · Weitz et al. · 2021 [cited by applicant]
US 20210348203A1 · Weitz et al. · 2021 [cited by applicant]
US 20230045126A1 · Weitz et al. · 2023 [cited by applicant]
CN 1477208A · 2004 [cited by applicant]
CN 101275164A · 2008 [cited by applicant]
CN 102260747A · 2011 [cited by applicant]
CN 102648053A · 2012 [cited by applicant]
CN 107406886A · 2017 [cited by applicant]
CN 108430617A · 2018 [cited by applicant]
CN 2022112807904 · 2024 [cited by applicant]
CN 202180009121 · 2024 [cited by applicant]
EP 167654912 · 2023 [cited by applicant]
EP 217415439 · 2023 [cited by applicant]
WO WO9109967A1 · 1991 [cited by applicant]
WO WO2004002627A2 · 2004 [cited by applicant]
WO WO2004091763A2 · 2004 [cited by applicant]
WO WO2005021151A1 · 2005 [cited by applicant]
WO WO2006096571A2 · 2006 [cited by applicant]
WO WO2008109176A2 · 2008 [cited by applicant]
WO WO2010033200A2 · 2010 [cited by applicant]
WO WO2010080134A1 · 2010 [cited by applicant]
WO WO2010151776A2 · 2010 [cited by applicant]
WO WO2011056546A1 · 2011 [cited by applicant]
WO WO2012048341A1 · 2012 [cited by applicant]
WO WO2012156744A1 · 2012 [cited by applicant]
WO WO2012156744A2 · 2012 [cited by examiner]
WO WO2013134261A1 · 2013 [cited by applicant]
WO WO2013192351A1 · 2013 [cited by applicant]
WO WO2014047561A1 · 2014 [cited by applicant]
WO WO2014145555A1 · 2014 [cited by applicant]
WO WO2014153651A1 · 2014 [cited by applicant]
WO WO2014186440A2 · 2014 [cited by applicant]
WO WO2014194131A2 · 2014 [cited by applicant]
WO WO2015035108A1 · 2015 [cited by applicant]
WO WO2015103339A1 · 2015 [cited by applicant]
WO WO2015160919A1 · 2015 [cited by applicant]
WO WO2015161177A1 · 2015 [cited by applicant]
WO WO2015161223A1 · 2015 [cited by applicant]
WO WO2015164212A1 · 2015 [cited by applicant]
WO WO2016118870A1 · 2016 [cited by applicant]
WO WO2016149096A1 · 2016 [cited by applicant]
WO WO2017184707A1 · 2017 [cited by applicant]
WO WO2022047154A2 · 2022 [cited by applicant]
Canadian Office Action for Application No. CA 2945798 mailed Mar. 3, 2022. [cited by applicant]
Canadian Office Action for Application No. CA 2945798 mailed Feb. 21, 2023. [cited by applicant]
Chinese Office Action for Application No. CN 201680015401.1 mailed May 28, 2020. [cited by applicant]
Chinese Office Action for Application No. CN 201680015401.1 mailed Jan. 5, 2021. [cited by applicant]
Chinese Office Action for Application No. CN 201680015401.1 mailed Jun. 15, 2021. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2016/014531 mailed Apr. 1, 2016. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2016/014531 mailed Aug. 3, 2017. [cited by applicant]
Chinese Office Action for Application No. CN 201680027136.9 mailed Feb. 21, 2019. [cited by applicant]
Chinese Office Action for Application No. CN 201680027136.9 mailed Oct. 12, 2019. [cited by applicant]
Chinese Office Action for Application No. CN 201680027136.9 mailed Feb. 6, 2020. [cited by applicant]
Chinese Office Action for Application No. CN 201680027136.9 mailed Feb. 25, 2022. [cited by applicant]
Chinese Office Action for Application No. CN 201680027136.9 mailed Aug. 25, 2022. [cited by applicant]
Extended European Search Report for Application No. EP 16765491.2 mailed Jul. 13, 2018. [cited by applicant]
European Office Action for Application No. 16765491.2 mailed Nov. 18, 2019. [cited by applicant]
European Office Action for Application No. EP 16765491.2 mailed Aug. 4, 2020. [cited by applicant]
European Office Action for Application No. EP 16765491.2 mailed Jan. 24, 2022. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2016/022021 mailed May 23, 2016. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2016/022021 mailed Sep. 28, 2017. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2017/028329 mailed Jul. 26, 2017. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2017/028329 mailed Nov. 1, 2018. [cited by applicant]
International Search Report and Written Opinion dated Mar. 31, 2021 for Application No. PCT/US2021/013231. [cited by applicant]
International Preliminary Report on Patentability dated Jul. 28, 2022 for Application No. PCT/US2021/013231. [cited by applicant]
Alix-Panabières et al. Challenges in circulating tumour cell research. Nat Rev Cancer. Sep. 2014;14(9):623-31. doi: 10.1038/nrc3820. [cited by applicant]
Chang et al., Integrated polymerase chain reaction chips utilizing digital microfluidics. Biomed Microdevices. 2006;8(3):215-225. [cited by applicant]
Duffy et al.Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). Anal Chem. Dec. 1, 1998;70(23):4974-4984. doi: 10.1021/ac980656z. [cited by applicant]
Eastburn et al. Identification and genetic analysis of cancer cells with PCR-activated cell sorting. Nucleic Acids Res. Jul. 2014;42(16):e128. doi: 10.1093/nar/gku606. [cited by applicant]
Geng et al., Single-cell forensic short tandem repeat typing within microfluidic droplets. Anal Chem. Jan. 7, 2014;86(1):703-12. doi: 10.1021/ac403137h. Epub Nov. 22, 2013. [cited by applicant]
Leamon et al., A massively parallel PicoTiterPlate based platform for discrete picoliter-scale polymerase chain reactions [published correction appears in Electrophoresis. Apr. 2004;25(7-8):1176]. Electrophoresis. 2003;… [cited by applicant]
Margulies et al., Genome sequencing in microfabricated high-density picolitre reactors [published correction appears in Nature. May 4, 2006;441(7089):120. Ho, Chun He corrected to Ho, Chun Heen]]. Nature. 2005;437(7057)… [cited by applicant]
Mensink et al., Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukemia patients using real-time quantitative RT-PCR. Br J Haematol. 1998;102(3):768-774. [cited by applicant]
Oberholzer et al., Polymerase chain reaction in liposomes. Chem Biol. 1995;2(10):677-682. [cited by applicant]
Oyola et al. Efficient depletion of host DNA contamination in malaria clinical sequencing. J Clin Microbiol. Mar. 2013;51(3):745-51. doi: 10.1128/JCM.02507-12. [cited by applicant]
Sepp et al., Microbead display by in vitro compartmentalization: selection for binding using flow cytometry. FEBS Lett. 2002;532(3):455-458. [cited by applicant]
Tawfik et al., Man-made cell-like compartments for molecular evolution. Nat Biotechnol. 1998;16(7):652-656. [cited by applicant]
Yan et al., Practical genetic disease diagnosis and prenatal diagnosis technology. Science and Technical Documentation Press. Jul. 21, 2014:98-99. Translation. [cited by applicant]
Zeng et al., High-performance single cell genetic analysis using microfluidic emulsion generator arrays. Anal Chem. 2010;82(8):3183-3190. [cited by applicant]
Zhu et al., Highly sensitive and quantitative detection of rare pathogens through agarose droplet microfluidic emulsion PCR at the single-cell level. Lab Chip. 2012;12(20):3907-3913. [cited by applicant]
Summons to Attend Oral Proceedings dated Jun. 26, 2024 for Application No. EP 16765491.2. [cited by applicant]
Canadian Office Action mailed Aug. 8, 2024 for Application No. CA 3021735. [cited by applicant]
Chinese Office Action mailed Jul. 26, 2024 for Application No. CN 202180009121.0. [cited by applicant]
[No Author Listed] Droplet Digitial™0 PCR Droplet Digital™ PR Applications Guide. Feb. 1, 2010. https://www.bio-rad.com/webroot/web/pdf/lsr/literature/Bulletin_6407.pdf. [Last accessed Jan. 3, 2024]. [cited by applicant]
[No Author Listed] RainDrop Assay Guidelines for RainDrop and RainDrop Pluxs Digital PCR Systems. RainDance Technologies. Dec. 31, 2016. https://www.accela.eu/files/products/124/lcn_50_04334_rev_d_raindrop_assay_guideli… [cited by applicant]
Baker et al., Environmental DNA (eDNA) From the Wake of the Whales: Droplet Digital PCR for Detection and Species Identification. Frontiers in Marine Science. Apr. 19, 2018;5:1-11. doi: 10.3389/fmars.2018.00133. [cited by applicant]
Basu, Digital Assays Part I: Partitioning Statistics and Digital PCR. SLAS Technol. Aug. 2017;22(4):369-386. doi: 10.1177/2472630317705680. Epub Apr. 27, 2017. [cited by applicant]
Kopp et al., Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice. Gastroenterology. Apr. 2018; 154(5):1509-1523.e5. doi: … [cited by applicant]
Liu et al., Research Status and Trend of Digital PCR based on Microdroplet Technology. Chem Research and App. Jul. 15, 2018;7:1041-47. [cited by applicant]
Novak et al., Single-cell multiplex gene detection and sequencing with microfluidically generated agarose emulsions. Angew Chem Int Ed Engl. Jan. 10, 2011;50(2):390-5. doi: 10.1002/anie.201006089. [cited by applicant]
Novak et al., Single-Cell Multiplex Gene Detection and Sequencing with Microfluidically Generated Agarose Emulsions. Angew Chem Int Ed Engl. Jan. 10, 2011;50(2):390-5. https://onlinelibrary.wiley.com/doi/10.1002/anie.20… [cited by applicant]
Schuler et al., Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals. Int J Cancer. Feb. 15, 2009;124(4):958-63. doi: 10.1002/ijc.23958. [cited by applicant]
U.S. Appl. No. 17/790,450, filed Nov. 20, 2020, Weitz et al. [cited by applicant]
U.S. Appl. No. 17/790,450, filed Jun. 30, 2022, Weitz et al. [cited by applicant]
Chinese Office Action mailed Nov. 5, 2024 for Application No. CN 202211280790.4. [cited by applicant]
European Office Action mailed Sep. 20, 2023 for Application No. EP 16765491.2. [cited by applicant]
Chinese Office Action mailed Dec. 20, 2024 for Application No. CN 202180009121. [cited by applicant]
Extended European Search Report mailed Dec. 6, 2023 for Application No. EP 21741543.9. [cited by applicant]
European Office Action mailed Oct. 30, 2024 for Application No. EP 21741543.9. [cited by applicant]
Joensson et al., Droplet microfluidics—a tool for single-cell analysis. Angew Chem Int Ed Engl. Dec. 3, 2012;51(49):12176-92. doi: 10.1002/anie.201200460. Epub Nov. 23, 2012. [cited by applicant]
Maheux et al., Ability of three DNA-based assays to identify presumptive [cited by applicant]
Yamazaki et al., Multiplex polymerase chain reaction method discriminating [cited by applicant]